Cargando…

Drugs foresight 2020: a Delphi expert panel study

BACKGROUND: Historically substance misuse has been relatively common in western countries, but comparatively few Finns report drug use. The Drugs 2020 study aimed at foreseeing changes in the drug situation in Finland by the year 2020. METHODS: The Delphi method was used, utilizing drug experts of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lintonen, Tomi, Konu, Anne, Rönkä, Sanna, Kotovirta, Elina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018972/
https://www.ncbi.nlm.nih.gov/pubmed/24885142
http://dx.doi.org/10.1186/1747-597X-9-18
_version_ 1782480134316490752
author Lintonen, Tomi
Konu, Anne
Rönkä, Sanna
Kotovirta, Elina
author_facet Lintonen, Tomi
Konu, Anne
Rönkä, Sanna
Kotovirta, Elina
author_sort Lintonen, Tomi
collection PubMed
description BACKGROUND: Historically substance misuse has been relatively common in western countries, but comparatively few Finns report drug use. The Drugs 2020 study aimed at foreseeing changes in the drug situation in Finland by the year 2020. METHODS: The Delphi method was used, utilizing drug experts of the EU national network in Finland. RESULTS: Marked growth was foreseen in drug use, especially in synthetic designer drugs and misuse of medicinal drugs. Significant increase was also expected in growing cannabis at home. However, the control of drug market was expected to shift more into the hands of organized crime. No consensus was reached on how drug prices will develop in the time period. Drug use is likely to remain punishable although the use and possession of cannabis may be treated less severely. It seems likely that health and social services resources will be directed towards medicinal treatment. CONCLUSIONS: Foresight can be utilized in preparing for the future; desirable developments can be fostered, and measures can be taken to curb probable but undesirable lines of development. Based on the results of this study, the experts’ view is that it is highly likely that the Finnish society will have to prepare for an increase in the demand for drug-related care, both in terms of content of the care and financing the services. Also, the forecasted increase in the role of legal prescription medicine used as intoxicants will call for efforts not only in changing prescription practices but in border and police control measures, as well. Parallel developments have been foreseen in the UK and Sweden, and it is likely that similar trends will actualize also in other western countries.
format Online
Article
Text
id pubmed-4018972
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40189722014-05-14 Drugs foresight 2020: a Delphi expert panel study Lintonen, Tomi Konu, Anne Rönkä, Sanna Kotovirta, Elina Subst Abuse Treat Prev Policy Research BACKGROUND: Historically substance misuse has been relatively common in western countries, but comparatively few Finns report drug use. The Drugs 2020 study aimed at foreseeing changes in the drug situation in Finland by the year 2020. METHODS: The Delphi method was used, utilizing drug experts of the EU national network in Finland. RESULTS: Marked growth was foreseen in drug use, especially in synthetic designer drugs and misuse of medicinal drugs. Significant increase was also expected in growing cannabis at home. However, the control of drug market was expected to shift more into the hands of organized crime. No consensus was reached on how drug prices will develop in the time period. Drug use is likely to remain punishable although the use and possession of cannabis may be treated less severely. It seems likely that health and social services resources will be directed towards medicinal treatment. CONCLUSIONS: Foresight can be utilized in preparing for the future; desirable developments can be fostered, and measures can be taken to curb probable but undesirable lines of development. Based on the results of this study, the experts’ view is that it is highly likely that the Finnish society will have to prepare for an increase in the demand for drug-related care, both in terms of content of the care and financing the services. Also, the forecasted increase in the role of legal prescription medicine used as intoxicants will call for efforts not only in changing prescription practices but in border and police control measures, as well. Parallel developments have been foreseen in the UK and Sweden, and it is likely that similar trends will actualize also in other western countries. BioMed Central 2014-05-03 /pmc/articles/PMC4018972/ /pubmed/24885142 http://dx.doi.org/10.1186/1747-597X-9-18 Text en Copyright © 2014 Lintonen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lintonen, Tomi
Konu, Anne
Rönkä, Sanna
Kotovirta, Elina
Drugs foresight 2020: a Delphi expert panel study
title Drugs foresight 2020: a Delphi expert panel study
title_full Drugs foresight 2020: a Delphi expert panel study
title_fullStr Drugs foresight 2020: a Delphi expert panel study
title_full_unstemmed Drugs foresight 2020: a Delphi expert panel study
title_short Drugs foresight 2020: a Delphi expert panel study
title_sort drugs foresight 2020: a delphi expert panel study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018972/
https://www.ncbi.nlm.nih.gov/pubmed/24885142
http://dx.doi.org/10.1186/1747-597X-9-18
work_keys_str_mv AT lintonentomi drugsforesight2020adelphiexpertpanelstudy
AT konuanne drugsforesight2020adelphiexpertpanelstudy
AT ronkasanna drugsforesight2020adelphiexpertpanelstudy
AT kotovirtaelina drugsforesight2020adelphiexpertpanelstudy